BIOVAXYS TECHNOLOGY CORP. BioVaxys Technology Corp announced a non-brokered private placement consisting of up to 15,384,615 units at a price of CAD 0.065 per Unit for total gross proceeds of up to CAD 1,000,000 on March 22, 2024. Each Unit consists of one common share and one whole Common Share purchase warrant. Each Warrant is exercisable for one additional Common Share at an exercise price of CAD 0.15 for a period of 24 months.
Closing of the private placement is conditional upon finalizing all contractual documentation and receipt of all applicable regulatory approvals and the policies of the Canadian Securities Exchange. All securities issued pursuant to the Private Placement are subject to a statutory hold period of four months and one day from the date of issuance.
